Department of Chemistry, Faculty of Science, Marmara University, Istanbul, Türkiye; Department of Analytical Chemistry, Faculty of Pharmacy, Istanbul Aydin University, Istanbul, Türkiye.
Department of Medical Biology and Genetics, Faculty of Medicine, Istanbul Aydin University, Istanbul, Türkiye.
Int J Biol Macromol. 2024 Jun;272(Pt 1):132710. doi: 10.1016/j.ijbiomac.2024.132710. Epub 2024 May 31.
Breast cancer is one of the leading causes of death in women and is a prevalent kind of cancerous growth, representing a substantial risk to women's health. Early detection of breast cancer is essential for effective treatment and improved survival rates. Biomarkers, active substances that signal the existence and advancement of a tumor, play a significant role in the early detection of breast cancer. Hence, accurate identification of biomarkers for tumors is crucial for diagnosing and treating breast cancer. However, the primary diagnostic methods used for the detection of breast cancer require specific equipment, skilled professionals, and specialized analysis, leading to elevated detection expenses. Regarding this obstacle, recent studies emphasize electrochemical biosensors as more advanced and sensitive detection tools compared to traditional methods. Electrochemical biosensors are employed to identify biomarkers that act as unique indicators for the onset, recurrence, and monitoring of therapeutic interventions for breast cancer. This study aims to provide a summary of the electrochemical biosensors that have been employed for the detection of breast cancer at an early stage over the past decade. Initially, the text provides concise information about breast cancer and tumor biomarkers. Subsequently, an in-depth analysis is conducted to systematically review the progress of electrochemical biosensors developed for the stable, specific, and sensitive identification of biomarkers associated with breast cancer. Particular emphasis was given to crucial clinical biomarkers, specifically the human epidermal growth factor receptor-2 (HER2). The analysis then explores the limitations and challenges inherent in the design of effective biosensors for diagnosing and treating breast cancer. Ultimately, we provided an overview of future research directions and concluded by outlining the advantages of electrochemical biosensor approaches.
乳腺癌是导致女性死亡的主要原因之一,也是一种常见的癌性生长,对女性健康构成重大威胁。早期发现乳腺癌对于有效治疗和提高生存率至关重要。生物标志物是指示肿瘤存在和进展的活性物质,在乳腺癌的早期检测中发挥着重要作用。因此,准确识别肿瘤标志物对于诊断和治疗乳腺癌至关重要。然而,用于检测乳腺癌的主要诊断方法需要特定的设备、熟练的专业人员和专门的分析,导致检测费用增加。关于这一障碍,最近的研究强调电化学生物传感器作为比传统方法更先进和敏感的检测工具。电化学生物传感器用于识别生物标志物,这些标志物是乳腺癌发生、复发和治疗干预监测的独特指标。本研究旨在综述过去十年中用于早期检测乳腺癌的电化学生物传感器。首先,文本提供了关于乳腺癌和肿瘤生物标志物的简要信息。随后,对用于稳定、特异性和敏感识别与乳腺癌相关生物标志物的电化学生物传感器的进展进行了系统的综述。特别强调了关键的临床生物标志物,特别是人表皮生长因子受体-2(HER2)。然后分析探讨了设计用于诊断和治疗乳腺癌的有效生物传感器的设计中固有的局限性和挑战。最终,我们概述了未来的研究方向,并总结了电化学生物传感器方法的优势。